BIOLINERX     Print Page  Close Window

SEC filings
424B5
BIOLINERX LTD. filed this Form 424B5 on 07/26/2017
Entire Document
 

USE OF PROCEEDS
 
Unless otherwise indicated in an accompanying prospectus supplement, the net proceeds from the sale of securities will be used for general corporate purposes.
 
6